|Study Type:||Phase III|
|Study Start Date:||NA|
|Study Made Public:||NA|
The correlate of risk targeted intervention study (CORTIS): A randomized, partially-blinded, clinical trial of isoniazid and rifapentine (3HP) therapy to prevent pulmonary tuberculosis in high-risk individuals identified by a transcriptomic correlate of risk
CORTIS-01 is a clinical trial to evaluate a preventive therapy using isoniazid and rifapentine (3HP) in individuals at high-risk for TB disease identified by transcriptomic-based correlate of risk (COR).
Sign in to see full information about this study and to download study data.